ICS 2014 Scientific Podium Poster Session S20 - Lower Urinary Tract Symptoms in Women 1

Lower Urinary Tract Symptoms in Women 1

Scientific Podium Poster Session S20

Speakers
	Wednesday 22nd October 2014
	14:30 - 16:00
	Room 3
L Linda Brubaker ICS Chair S Simone Dos Reis Brandao da Silveira Local Chair

Session Schedule

15:00

#324 Home and group supervised physiotherapy for women with urinary incontinence in the primary care of SUS in Brazil.

Figueiredo E M¹, Vaz C², Sampaio R³
1. Physical Therapy Department, Rehabilitation Sciences Program, Universidade Federal de Minas Gerais, 2. Rehabilitation Sciences Program, Universidade Federal de Minas Gerais, 3. Physical Therapy Department and Rehabilitation Sciences Program, Universidade Federal de Minas Gerais
Physiotherapy, Stress Urinary Incontinence, Pelvic Floor

15:05

#325 An expert system to enhance patient self-management of fluid intake

Gammie A¹, Long A², Casey L³
1. Bristol Urological Institute, UK, 2. Cx Products and Services, UK, 3. University of West of England, UK
Conservative Treatment, Incontinence, New Devices, Prevention, Rehabilitation

15:10

#326 Assessment of overactive bladder and urgency urinary incontinence six weeks after vaginal delivery

Diez Itza I¹, Goyeneche L¹, Uranga S¹, Salgueiro D¹, Goiri C¹, Lekuona A¹
1. Hospital Universitario Donostia
Overactive Bladder, Female

15:15

#327 OnabotulinumtoxinA Demonstrates Similar Improvements in Urinary Incontinence and Quality of Life Regardless of the Use of Clean Intermittent Catheterisation or the Presence of Urinary Tract Infection in Patients with Overactive Bladder

Everaert K¹, Gruenenfelder J², Schulte-Baukloh H³, Guard S⁴, Zheng Y⁵, Sussman D⁶
1. Ghent University Hospital, Gent, Belgium, 2. Orange County Urology Associates, Laguna Hills, CA, USA, 3. St. Hedwig-Krankenhaus, Berlin, Germany, 4. Allergan Ltd, Marlow, United Kingdom, 5. Allergan Inc, Bridgewater, NJ, USA, 6. Rowan University School of Osteopathic Medicine, Stratford, NJ, USA
Incontinence, Overactive Bladder, Quality of Life (QoL), Voiding Dysfunction , Clinical Trial

15:20

#328 Efficacy and safety of initial 10mg solifenacin treatment in female OAB patients

Yoon H¹, Lee D H¹, Chung W S¹, Hong J Y², Cho S T³
1. Ewha Womans University, 2. Cha University, 3. Hanllym University
Female, Overactive Bladder, Prospective Study

15:25

#329 Does S3 or S4 stimulation confer favourable results in sacral nerve stimulation for functional bladder problems?

Chandra L¹, Lunawat R¹, Harris N¹
1. Leeds Teaching Hospitals
Neuromodulation, Urgency/Frequency, Retrospective Study

15:30

#330 A cost-effectiveness analysis of onabotulinumtoxinA for overactive bladder in patients who are inadequately managed with anticholinergic medications in Spain.

Errando-Smet C¹, Larrea G², Cidre J³, Loveman C⁴, Khalaf K⁵, Aracil J⁶, Stanisic S⁷, Lister J⁸
1. Fundació Puigvert, Barcelona, Spain, 2. Hospital Donostia, Gipuzkoa, Spain, 3. Hospital Universitario Ramón y Cajal, Madrid, Spain, 4. Allergan Limited, Marlow, UK, 5. Allergan, Inc., Irvine CA, USA, 6. Allergan España, Madrid, Spain, 7. La-ser Analytica, Milano, Italy, 8. La-ser Analytica, Lörrach, Germany
Overactive Bladder, Incontinence, Detrusor Overactivity, Urgency Urinary Incontinence

15:35

#331 Multicenter Analysis of 10 Years Follow up after Repeat Intravesical Botulinum toxin-A Injections in Patients with Detrusor Overactivity

Rahnama'i M¹, Marcelissen T², Ong F³, Snijders J⁴, De Vries P², van Koeveringe G⁴
1. Maastricht University Medical Centre, 2. Atrium Medical Centre Parkstad, Heerlen, The Netherlands, 3. Orbis Medical Centre, Sittard, The Netherlands, 4. Maastricht Medical Centre +, The Netherlands
Detrusor Overactivity, Incontinence, Surgery, Female, Overactive Bladder

15:40

#332 Dorsal Onlay Buccal Urethoplasty (DOBU) in the Female is Durable and Is Not Associated with Incontinence Using LUTS Instruments Validated in Females

Powell C¹, Daniels D¹
1. Indiana University School of Medicine
Bladder Outlet Obstruction , Female, Grafts: Biological, Quality of Life (QoL), Surgery

15:45

#333 Is there a relationship between the complaints of the amount of urine loss and their objective and subjective measurements?

Vasconcelos C T M¹, Vasconcelos Neto J A², Bezerra L R P S¹, Karbage S A L³, Frota I P R⁴, Bezerra K C¹, Bizarria L B⁵, Macedo S R⁶, Augusto K L⁷, Rocha A B O⁴, Oriá M O B¹, Santos Z M S A³
1. Universidade Federal do Ceará (UFC), Fortaleza, Brazil, 2. Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil, 3. Universidade de Fortaleza (UNIFOR), Fortaleza, Brazil, 4. Universidade de São Paulo (USP), Brazil, 5. Hospital Geral de Fortaleza, Brazil, 6. Universidade Christus (Unicristus), Fortaleza, Brazil, 7. Hospital Geral de Fortaleza
Incontinence, Quality of Life (QoL), Pad Test

15:50

#334 Acupuncture in the management of Overactive Bladder Syndrome

Li C¹, Pakzad M², Lee J¹, Green J¹, Philp T¹
1. Whipps Cross University Hospital, 2. University College London Hospital
Overactive Bladder, Urgency/Frequency, Detrusor Overactivity, Urgency Urinary Incontinence

15:55

#335 Urothelial dysfunction and chronic Inflammation in diabetes mellitus patients with overactive bladder syndrome: An immunohistochemistry study

Lee C¹, Liu H¹, Wang C², Kuo H¹
1. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan, 2. Departmentn of Urology, En Chu Kong Hospital, New Taipei, Taiwan
Overactive Bladder, Pathophysiology, Urgency/Frequency